CA Patent

CA3108848A1 — Process for preparing jak inhibitors and intermediates thereof

Assigned to Theravance Biopharma R&D IP LLC · Expires 2020-03-12 · 6y expired

What this patent protects

The invention is directed to a process for preparing compounds which are useful as intermediates for the preparation of medicinal agents having inhibitory activity for JAK.

USPTO Abstract

The invention is directed to a process for preparing compounds which are useful as intermediates for the preparation of medicinal agents having inhibitory activity for JAK.

Drugs covered by this patent

Patent Metadata

Patent number
CA3108848A1
Jurisdiction
CA
Classification
—
Expires
2020-03-12
Drug substance claim
No
Drug product claim
No
Assignee
Theravance Biopharma R&D IP LLC
Source
FDA Orange Book + USPTO grounding via Google Patents

Bibliographic data sourced from FDA Orange Book + USPTO public records. Plain-English summary generated by AI grounded in source text. Patent term extensions (PTR, SPC, pediatric) may shift the effective expiry. Not legal advice.

Track this patent

Get a daily-checked alert when vulnerability score, expiry, classification, or assignee changes. Email, Slack, or Teams delivery. Pro: 50 watches, Free: 3.